Xinhua
26 Dec 2022, 14:25 GMT+10
BEIJING, Dec. 26 (Xinhua) -- A total of 13 types of COVID-19 vaccines, approved for conditional marketing or emergency use, are now available as a second booster dose in China, according to experts with the State Council inter-agency task force for COVID-19 response.
Omicron-resistant vaccines are preferred in choosing second booster doses, said experts with the State Council joint prevention and control mechanism against COVID-19.
As of Friday, more than 3.46 billion COVID-19 vaccine doses had been administered on the Chinese mainland, with over 90 percent of the population fully vaccinated.
The level of antibodies will drop over time after vaccination, experts said, adding that virus mutations also lead to strengthened immune evasion, making antibodies less effective.
Studies show that getting a booster jab can activate the immunological memory cells in the subject's body and increase the antibody levels, so as to further consolidate the prevention of severe illness and death, experts said.
They suggested eligible people who have not received a booster shot should get one as soon as possible to get better protection against the virus.
Population groups with a high risk of infection, people aged 60 and above, people with serious underlying health conditions, and those with low immunity are advised to receive a second booster shot six months after the first one.
Those who have received three doses of inactivated vaccines can choose a different type of vaccine -- recommended by the government -- for the second booster, namely a recombinant protein vaccine, an adenovirus vector vaccine or an influenza virus vector vaccine, according to the experts.
The Chinese Center for Disease Control and Prevention has conducted monitoring of adverse reactions to COVID-19 vaccines based on over 3.4 billion inoculations administered to over 1.3 billion people.
The monitoring results showed that the incidence rate of adverse reactions to COVID-19 vaccines is similar to those of other common vaccines, and that the incidence rate of adverse reactions for the elderly is slightly lower than that of young people.
Get a daily dose of Shanghai Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Shanghai Sun.
More InformationENNIS, Texas: A man died, and three of his family members were injured when their RV flipped several times during a strong storm at...
One halcyon spring day in 1903, the 69-year-old anatomist and naturalist Dr. James Bell Pettigrew sat at the top of a sloping street...
WEST PALM BEACH, Florida: Air Force fighter jets have stopped a civilian plane that entered restricted airspace near Donald Trump's...
CHICAGO/WASHINGTON, D.C.: Farmers and food groups across the U.S. are laying off workers, stopping investments, and struggling to get...
SIOUX FALLS, South Dakota: A new South Dakota law banning the use of eminent domain for carbon capture pipelines has cast doubt on...
WASHINGTON, D.C.: Officials working on diversity and inclusion programs at the U.S. Office of the Director of National Intelligence...
BENTONVILLE, Arkansas: Walmart is pressuring some Chinese suppliers to cut prices in response to President Donald Trump's imposed U.S....
NEW DELHI, India: The United States is pressing India to lower tariffs and increase defense purchases to secure a stronger bilateral...
BEIJING, China: China has set an economic growth target of around five percent for 2025, signaling efforts to stabilize the economy...
Humanoid robots are trained to swing their arms at the Zhejiang humanoid robot innovation center in Ningbo, east China's Zhejiang Province,...
New Delhi [India], March 12 (ANI): Delhi Lieutenant Governor VK Saxena, along with Chief Minister Rekha Gupta, on Wednesday chaired...
New Delhi [India], March 12 (ANI): Union Minister of Jal Shakti C.R. Patil chaired the 14th meeting of the Empowered Task Force (ETF)...